Synthetic biology and occupational risk

  title={Synthetic biology and occupational risk},
  author={John Howard and Vladimir V. Murashov and Paul A. Schulte},
  journal={Journal of Occupational and Environmental Hygiene},
  pages={224 - 236}
ABSTRACT Synthetic biology is an emerging interdisciplinary field of biotechnology that involves applying the principles of engineering and chemical design to biological systems. Biosafety professionals have done an excellent job in addressing research laboratory safety as synthetic biology and gene editing have emerged from the larger field of biotechnology. Despite these efforts, risks posed by synthetic biology are of increasing concern as research procedures scale up to industrial processes… 

Biosafety and biosecurity in Synthetic Biology: A review

Abstract Synthetic Biology is a growing field which holds great promise in several areas of application. However, it also poses serious risks for human health and the environment that must be

Synthetic Biology Industry: Biosafety Risks to Workers

Synthetic biology involves the design, assembly, synthesis, or manufacture of new genomes, biological pathways, devices, or organisms not found in nature for use in agriculture, bio-manufacturing, health care, energy, and other industrial sectors.

Development of community of practice to support quantitative risk assessment for synthetic biology products: contaminant bioremediation and invasive carp control as cases

It is concluded that, while synthetic biology risk assessment and governance will continue to refine and develop in the coming years, a quantitative framework that builds from existing practice is one potentially beneficial option for risk assessors that must contend with the technology’s limited hazard characterization or exposure assessment considerations in the near term.

A quantitative risk assessment method for synthetic biology products in the environment

The Quantitative Risk Assessment Method for Synthetic Biology Products (QRASynBio) is proposed – an incremental build on established risk assessment methodologies that supplements traditional paradigms with the SynBio risk factors that are currently absent and necessitates quantitative analysis for more transparent and objective risk characterizations.

Characterization of Viral Exposures in United States Occupational Environments

  • T. Croston
  • Medicine
    Exposure to Microbiological Agents in Indoor and Occupational Environments
  • 2017
The characteristics of viruses and the occupationally relevant viruses of which people in varying occupations can potentially encounter are discussed and regulatory guidelines and protective strategies will also be reviewed.

High-risk human-caused pathogen exposure events from 1975-2016

Biological agents and infectious pathogens have the potential to cause very significant harm, as the natural occurrence of disease and pandemics makes clear. As a way to better understand the risk of

Synthetic Biology, GMO, and Risk: What Is New, and What Is Different?

The term synthetic biology is a point of significant contention in both academic and policy circles, and has implications ranging from regulatory requirements and risk-based testing challenges to communication with an often concerned and skeptical public.

High-risk human-caused pathogen exposure events from 1975-2016 [version 1; peer review: awaiting peer review]

Biological agents and infectious pathogens have the potential to cause very significant harm, as the natural occurrence of disease and pandemics makes clear. As a way to better understand the risk of

On future occupational safety and health challenges in industrialized countries — a systematic literature review

The aim of this systematic literature review was to give an overview of future OSH challenges in industrialized countries and branch-specific challenges in industries and health care.

Need for a new workplace safety and health (WSH) strategy for the fourth Industrial Revolution

A new WSH 4.0 strategy is argued for which requires WSH professionals to adopt an adaptive and highly responsive approach to promote Total Worker Health in the face of rapid technological advancements and changes in employment relationships.



Synthetic Biology: Regulating Industry Uses of New Biotechnologies

Improvements in the speed and cost of DNA synthesis are enabling scientists to design modified bacterial chromosomes that can be used in the production of renewable chemicals, biofuels, bioproducts, renewable specialty chemicals, pharmaceutical intermediates, fine chemicals, food ingredients, and health care products.

Synthetic Biology and the U.S. Biotechnology Regulatory System: Challenges and Options

The study concludes that the U.S. regulatory agencies have adequate legal authority to address most, but not all, potential environmental, health and safety concerns posed by these organisms.

Building-in biosafety for synthetic biology.

The state-of-the-art in designing for biosafety is summarized and general recommendations are made (e.g. short environmental retention times) for current synthetic biology projects to better isolate themselves against potentially negative impacts.

Preparing synthetic biology for the world

This review explains how studies of genetically modified organisms lay groundwork for the future landscape of biosafety, and surveys lessons learned, ongoing efforts to engineer intrinsic biocontainment, and how different stakeholders in synthetic biology can act to accomplish best practices for biosafety.

The promise and perils of synthetic biology.

Drawing upon a set of powerful techniques for the automated synthesis of DNA molecules and their assembly into genes and microbial genomes, synthetic biology envisions the redesign of natural biological systems for greater efficiency, as well as the construction of functional "genetic circuits" and metabolic pathways for practical purposes.

Safe and effective synthetic biology

The discussions at the NAKFI meeting included the value of revisiting the self-examination and self-regulation imposed on early adopters of recombinant DNA technology at the Asilomar meeting and how to create and improve inter-cellular communication.

A prudent path forward for genomic engineering and germline gene modification

The meeting identified immediate steps to take toward ensuring that the application of genome engineering technology is performed safely and ethically, and identified those areas where action is essential to prepare for future developments.

Multilayered genetic safeguards limit growth of microorganisms to defined environments

This work developed a new biocontainment strategy containing overlapping ‘safeguards’—engineered riboregulators that tightly control expression of essential genes, and an engineered addiction module based on nucleases that cleaves the host genome—to restrict viability of Escherichia coli cells to media containing exogenously supplied synthetic small molecules.

Synthetic Biology

The aim of this chapter is to introduce the field and discuss some key examples to date, which have in common a set of underlying molecular biology techniques including DNA assembly and combinatorial diversity generation, as well as computational modelling to assist in designing the new biological systems.

State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.

This review outlines the different strategies used to improve LV biosafety by comparing state-of-the-art and emerging LV production systems and highlighting biosafety issues that can arise during their contained use.